vs
Side-by-side financial comparison of Spero Therapeutics, Inc. (SPRO) and SurgePays, Inc. (SURG). Click either name above to swap in a different company.
SurgePays, Inc. is the larger business by last-quarter revenue ($16.2M vs $12.6M, roughly 1.3× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -85.6%, a 336.3% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 68.7%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -28.2%).
SurgePays, Inc. is a U.S.-headquartered fintech and telecommunications company focused on serving underbanked and low-income communities across the country. It offers prepaid wireless plans, reloadable debit cards, digital banking solutions, and daily consumer products through a nationwide network of independent local retail partners such as convenience stores.
SPRO vs SURG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.6M | $16.2M |
| Net Profit | $31.5M | $-13.9M |
| Gross Margin | — | -14.8% |
| Operating Margin | — | -79.1% |
| Net Margin | 250.7% | -85.6% |
| Revenue YoY | 24080.8% | 68.7% |
| Net Profit YoY | 250.9% | 30.0% |
| EPS (diluted) | $0.56 | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.6M | $16.2M | ||
| Q3 25 | $0 | $18.7M | ||
| Q2 25 | $0 | $11.5M | ||
| Q1 25 | $12.0K | $10.6M | ||
| Q4 24 | $52.0K | $9.6M | ||
| Q3 24 | $65.0K | $4.8M | ||
| Q2 24 | $114.0K | $15.1M | ||
| Q1 24 | $140.0K | $31.4M |
| Q4 25 | $31.5M | $-13.9M | ||
| Q3 25 | $-7.4M | $-7.5M | ||
| Q2 25 | $-1.7M | $-7.1M | ||
| Q1 25 | $-13.9M | $-7.6M | ||
| Q4 24 | — | $-19.8M | ||
| Q3 24 | $-17.1M | $-14.3M | ||
| Q2 24 | $-17.9M | $-12.9M | ||
| Q1 24 | $-12.7M | $1.2M |
| Q4 25 | — | -14.8% | ||
| Q3 25 | — | -13.9% | ||
| Q2 25 | — | -23.0% | ||
| Q1 25 | — | -27.8% | ||
| Q4 24 | — | -117.0% | ||
| Q3 24 | — | -164.2% | ||
| Q2 24 | — | -22.8% | ||
| Q1 24 | — | 26.0% |
| Q4 25 | — | -79.1% | ||
| Q3 25 | — | -37.2% | ||
| Q2 25 | — | -59.1% | ||
| Q1 25 | -122758.3% | -71.7% | ||
| Q4 24 | — | -209.0% | ||
| Q3 24 | -28604.6% | -299.4% | ||
| Q2 24 | -16720.2% | -72.1% | ||
| Q1 24 | -9987.1% | 5.6% |
| Q4 25 | 250.7% | -85.6% | ||
| Q3 25 | — | -40.1% | ||
| Q2 25 | — | -61.5% | ||
| Q1 25 | -115550.0% | -72.2% | ||
| Q4 24 | — | -206.5% | ||
| Q3 24 | -26380.0% | -299.3% | ||
| Q2 24 | -15668.4% | -85.3% | ||
| Q1 24 | -9049.3% | 3.9% |
| Q4 25 | $0.56 | $-0.68 | ||
| Q3 25 | $-0.13 | $-0.38 | ||
| Q2 25 | $-0.03 | $-0.36 | ||
| Q1 25 | $-0.25 | $-0.38 | ||
| Q4 24 | — | $-1.07 | ||
| Q3 24 | $-0.32 | $-0.73 | ||
| Q2 24 | $-0.33 | $-0.66 | ||
| Q1 24 | $-0.24 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.3M | $1.7M |
| Total DebtLower is stronger | — | $13.3M |
| Stockholders' EquityBook value | $59.0M | $-15.3M |
| Total Assets | $68.9M | $8.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.3M | $1.7M | ||
| Q3 25 | $48.6M | $2.5M | ||
| Q2 25 | $31.2M | $4.4M | ||
| Q1 25 | $48.9M | $5.4M | ||
| Q4 24 | $52.9M | $11.8M | ||
| Q3 24 | $76.3M | $23.7M | ||
| Q2 24 | $63.5M | — | ||
| Q1 24 | $82.3M | — |
| Q4 25 | — | $13.3M | ||
| Q3 25 | — | $12.0M | ||
| Q2 25 | — | $9.6M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $4.4M | ||
| Q2 24 | — | $4.8M | ||
| Q1 24 | — | $5.2M |
| Q4 25 | $59.0M | $-15.3M | ||
| Q3 25 | $26.5M | $-6.4M | ||
| Q2 25 | $32.8M | $116.1K | ||
| Q1 25 | $33.8M | $7.8M | ||
| Q4 24 | $46.1M | $15.3M | ||
| Q3 24 | $65.5M | $33.2M | ||
| Q2 24 | $80.5M | $46.2M | ||
| Q1 24 | $96.2M | $56.0M |
| Q4 25 | $68.9M | $8.5M | ||
| Q3 25 | $54.2M | $14.5M | ||
| Q2 25 | $62.1M | $15.2M | ||
| Q1 25 | $77.7M | $15.7M | ||
| Q4 24 | $110.5M | $24.0M | ||
| Q3 24 | $135.2M | $41.5M | ||
| Q2 24 | $149.9M | $56.4M | ||
| Q1 24 | $167.7M | $69.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 82.67× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.10× | ||
| Q1 24 | — | 0.09× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.4M | $-3.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.4M | $-3.6M | ||
| Q3 25 | $17.4M | $-4.6M | ||
| Q2 25 | $-17.7M | $-6.1M | ||
| Q1 25 | $-4.0M | $-7.0M | ||
| Q4 24 | $-23.4M | $-7.9M | ||
| Q3 24 | $12.8M | $-13.3M | ||
| Q2 24 | $-18.7M | $-4.1M | ||
| Q1 24 | $5.9M | $4.0M |
| Q4 25 | -0.26× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.30× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
